Illumina Inc. Reaches New 12-Month High at $122.35 (ILMN)
Illumina (NASDAQ:ILMN)’s share price reached a new 52-week high during trading on Tuesday, StockRatingsNetwork reports. The stock traded as high as $122.35 and last traded at $120.25, with a volume of 3,099,909 shares traded. The stock had previously closed at $113.93.
A number of analysts have recently weighed in on ILMN shares. Analysts at Mizuho raised their price target on shares of Illumina from $125.00 to $135.00 in a research note to investors on Tuesday. They now have a “buy” rating on the stock. Separately, analysts at Cowen and Company raised their price target on shares of Illumina to $125.00 in a research note to investors on Friday, December 20th. Seven research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The stock currently has an average rating of “Buy” and a consensus price target of $92.93.
In other Illumina news, CEO Jay Flatley sold 30,000 shares of the stock in a transaction that occurred on Thursday, January 9th. The stock was sold at an average price of $114.77, for a total value of $3,443,100.00. Following the completion of the transaction, the chief executive officer now directly owns 399,509 shares in the company, valued at approximately $45,851,648. The transaction was disclosed in a document filed with the SEC, which is available at this link.
Illumina has a one year low of $48.00 and a one year high of $117.50. The stock’s 50-day moving average is $104.8 and its 200-day moving average is $87.83. The company has a market cap of $15.235 billion and a P/E ratio of 135.95.
Illumina (NASDAQ:ILMN) last released its earnings data on Monday, October 21st. The company reported $0.45 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.40 by $0.05. The company had revenue of $357.00 million for the quarter, compared to the consensus estimate of $343.42 million. During the same quarter in the previous year, the company posted $0.41 earnings per share. The company’s revenue for the quarter was up 24.9% on a year-over-year basis. On average, analysts predict that Illumina will post $1.78 earnings per share for the current fiscal year.
Illumina, Inc (NASDAQ:ILMN) is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.